These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 2860879

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of mifentidine on mepirizole-induced duodenal ulcer in the rat.
    Brambilla A, Ghiorzi A, De Paoli AM, Giachetti A.
    Pharmacol Res Commun; 1987 Dec; 19(12):877-85. PubMed ID: 2896364
    [Abstract] [Full Text] [Related]

  • 24. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
    Agut J, Sánchez JC, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
    [Abstract] [Full Text] [Related]

  • 25. Studies on the active molecular species of the H2 receptor antagonists cimetidine and mifentidine.
    Haaksma EE, Rademaker B, Kramer K, Eriks JC, Bast A, Timmerman H.
    J Med Chem; 1987 Jan; 30(1):208-11. PubMed ID: 3806596
    [Abstract] [Full Text] [Related]

  • 26. Action of the new H2-antagonist, DA 4577, on different in vitro and in vivo preparations.
    Bertaccini G, Poli E, Coruzzi G.
    Agents Actions; 1984 Apr; 14(3-4):510-5. PubMed ID: 6145337
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
    Sekiguchi H, Hamada K, Kobayashi F, Taga F, Uchida H.
    Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
    [Abstract] [Full Text] [Related]

  • 33. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
    Daly MJ, Humphray JM, Stables R.
    Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
    [Abstract] [Full Text] [Related]

  • 34. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
    Del Soldato P, Ghiorzi A, Cereda E, Donetti A.
    Pharmacology; 1985 Jan; 30(1):45-51. PubMed ID: 2858110
    [Abstract] [Full Text] [Related]

  • 35. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR, Tankanow RM, Nostrant TT.
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ, Obtułowicz W, Kwiecień N, Kopp B, Oleksy J.
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [Abstract] [Full Text] [Related]

  • 38. Ranitidine and cimetidine differ in their in vitro and in vivo effects on human colonic cancer growth.
    Lawson JA, Adams WJ, Morris DL.
    Br J Cancer; 1996 Apr; 73(7):872-6. PubMed ID: 8611398
    [Abstract] [Full Text] [Related]

  • 39. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
    Coruzzi G, Adami M, Pozzoli C, Poli E, Bertaccini G.
    Pharmacology; 1994 Feb; 48(2):69-76. PubMed ID: 7907797
    [Abstract] [Full Text] [Related]

  • 40. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
    Pendleton RG, Torchiana ML, Chung C, Cook P, Wiese S, Clineschmidt BV.
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.